← Back to Events
🎤 Event

Biohacking Conference 2026 — Where Self-Optimization Meets Science (and Where It Doesn't)

📅 2026-09-12📍 Austin, TX

The annual biohacking conference brings together quantified-self enthusiasts, longevity researchers, and wellness entrepreneurs. Some presentations are backed by rigorous data. Others are selling dreams.

What to Expect

The Biohacking Conference (September 12-14, Austin TX) is the largest gathering of the self-optimization community. It draws a mix of legitimate researchers, clinician-entrepreneurs, biohacker influencers, and supplement companies — making it simultaneously one of the most interesting and most claims-dense events in the wellness space.

For BMS readers, the value is in separating the signal from the noise.

Sessions Worth Watching

Bryan Johnson's "Don't Die" Protocol: 2-Year Data

Blueprint's Bryan Johnson will present 24-month biomarker data from his comprehensive anti-aging protocol. Whatever you think of his approach, the data is real — frequent blood panels, DEXA scans, vascular imaging, and cognitive testing provide an unprecedented n=1 longitudinal dataset. The scientific question isn't whether he's healthier than average (he is) — it's whether the interventions are causing the improvements or whether the obsessive monitoring and lifestyle optimization would work without the 100+ daily supplements.

Cold Exposure Dose-Response Panel

A dedicated panel on cold exposure protocols will feature researchers from the Huberman Lab, Susanna Søberg's group in Denmark, and clinical practitioners. The focus: defining minimum effective dose, optimal frequency, and contraindications. This is the session most likely to produce actionable protocol refinements.

Continuous Monitoring and the "Quantified Self 2.0"

Presentations on next-generation continuous monitoring — glucose (CGM), cortisol (wearable patch), lactate (implantable sensor), and ketones (breath analyzer). The premise: real-time metabolic data enables personalized optimization at a granularity impossible with periodic blood tests. The counterargument: more data doesn't equal better decisions without the clinical framework to interpret it.

Psychedelic Microdosing: Controlled Trial Results

Two research groups will present RCT data on psilocybin microdosing for cognitive enhancement and mood. Previous placebo-controlled studies have largely shown that microdosing effects are indistinguishable from placebo expectancy. These new studies use active placebos (niacin) to better control for the "feeling something" expectancy effect.

The BMS Filter

The biohacking community operates at the frontier where enthusiasm outpaces evidence. Some of what's presented will become mainstream medicine in 10 years. Some is expensive placebo. The challenge is telling the difference in real time.

Our filter: Does the presenter cite peer-reviewed evidence? Is the evidence on their specific protocol or a related-but-different one? Are effect sizes reported honestly? Are limitations disclosed?

We'll be covering the sessions that pass this filter — and flagging the ones that don't.